Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction

被引:0
作者
Fortunati, Florent [1 ]
Froidure, Antoine [2 ]
Baldin, Pamela [3 ]
Horsmans, Yves [1 ]
Lanthier, Nicolas [1 ]
Dahlqvist, Geraldine [1 ]
Delire, Benedicte [1 ]
机构
[1] UCLouvain, Serv Hepato Gastroenterol, Clin Univ St Luc, Ave Hippocrate 10, B-1200 Brussels, Belgium
[2] UCLouvain, Serv Pneumol, Clin Univ St Luc, Brussels, Belgium
[3] UCLouvain, Serv Anatomopathol, Clin Univ St Luc, Brussels, Belgium
关键词
case report; drug-induced liver injury; idiosyncratic reaction; pirfenidone; DEFINITION; DIAGNOSIS; FEATURES; OUTCOMES;
D O I
10.1177/20420986241270866
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nearly all medications carry the risk of drug-induced liver injury (DILI). Idiosyncratic reactions are rare and poorly predictable, and the mechanisms are not always well understood. Pirfenidone is an oral antifibrotic drug used to treat idiopathic pulmonary fibrosis. While elevation of liver enzymes is a common adverse reaction during therapy, it rarely leads to discontinuation or reduction of the drug. Although isolated cases of liver damage or liver failure have been reported, they are infrequent. This report presents the case of a 70-year-old woman with known idiopathic pulmonary fibrosis, depression, hypothyroidism, and hypercholesterolemia who presented at our emergency department with jaundice, anorexia, and asthenia. The patient's medication regimen included lamotrigine, simvastatin, levothyroxine, and pirfenidone, which had been introduced 6 months prior. Laboratory testing revealed elevated liver enzyme levels consistent with acute hepatocellular hepatitis. Following a medical workup, which included anamnesis, laboratory testing, iconographic investigations, and liver biopsy, we concluded that the patient had suffered from pirfenidone-induced liver injury. Pirfenidone was withdrawn, and liver tests gradually improved. The purpose of this clinical case report is to highlight this rare adverse reaction and to make clinicians aware of its assessment and management. In 2018, only one other case of severe liver failure leading to the death of the patient was reported. Early detection of potential DILI during the workup is crucial to discontinue the suspected medication promptly. Any drug-induced hepatitis must be reported for registration. A case report of toxic hepatitis induced by drug (pirfenidone) in a patient with idiopathic pulmonary fibrosis center dot Drug-induced liver injury (DILI) is a type of hepatitis caused by medication, drugs, or even herbal and dietary supplements. center dot There are two types of DILI reactions: intrinsic and idiosyncratic. circle The intrinsic reaction, such as acute hepatotoxicity due to acetaminophen overdose, is easily predictable and well-known. circle The idiosyncratic reaction is more complex, unpredictable, and not well-understood. Therefore, diagnosing an idiosyncratic reaction can be challenging. center dot Pirfenidone is an immunosuppressive drug used to treat idiopathic pulmonary fibrosis by inhibiting collagen formation through anti-fibrotic and anti-inflammatory mechanisms. center dot Several adverse reactions of pirfenidone are well described, including temporary elevation of liver enzymes during treatment. This adverse reaction is mostly asymptomatic and resolves spontaneously with or without dose adjustment. center dot However, few cases of severe DILI due to pirfenidone have been reported, which may lead to liver dysfunction. center dot This paper reports on a rare idiosyncratic reaction related to pirfenidone that resulted in hepatic adverse reactions.
引用
收藏
页数:10
相关论文
共 21 条
  • [1] Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury
    Ahmad, Jawad
    Reddy, K. Rajender
    Tillmann, Hans L.
    Hayashi, Paul H.
    Chalasani, Naga
    Fontana, Robert J.
    Navarro, Victor J.
    Stolz, Andrew
    Barnhart, Huiman
    Cloherty, Gavin A.
    Hoofnagle, Jay H.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (09) : 2645 - 2652
  • [2] Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
    Aithal, G. P.
    Watkins, P. B.
    Andrade, R. J.
    Larrey, D.
    Molokhia, M.
    Takikawa, H.
    Hunt, C. M.
    Wilke, R. A.
    Avigan, M.
    Kaplowitz, N.
    Bjornsson, E.
    Daly, A. K.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 806 - 815
  • [3] [Anonymous], 2012, LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
  • [4] Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
    Antar, Samar A.
    Saleh, Mohamed A.
    Al-Karmalawy, Ahmed A.
    [J]. LIFE SCIENCES, 2022, 309
  • [5] Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
    Chalasani, Naga
    Bonkovsky, Herbert L.
    Fontana, Robert
    Lee, William
    Stolz, Andrew
    Talwalkar, Jayant
    Reddy, K. Rajendar
    Watkins, Paul B.
    Navarro, Victor
    Barnhart, Huiman
    Gu, Jiezhun
    [J]. GASTROENTEROLOGY, 2015, 148 (07) : 1340 - +
  • [6] Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-induced Liver Injury in the United States
    Chalasani, Naga
    Fontana, Robert J.
    Bonkovsky, Herbert L.
    Watkins, Paul B.
    Davern, Timothy
    Serrano, Jose
    Yang, Hongqiu
    Rochon, James
    [J]. GASTROENTEROLOGY, 2008, 135 (06) : 1924 - 1934
  • [7] ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
    Chalasani, Naga P.
    Maddur, Haripriya
    Russo, Mark W.
    Wong, Robert J.
    Reddy, K. Rajender
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (05) : 878 - 898
  • [8] CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .1. A NOVEL METHOD BASED ON THE CONCLUSIONS OF INTERNATIONAL CONSENSUS MEETINGS - APPLICATION TO DRUG-INDUCED LIVER INJURIES
    DANAN, G
    BENICHOU, C
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (11) : 1323 - 1330
  • [9] RUCAM in Drug and Herb Induced Liver Injury: The Update
    Danan, Gaby
    Teschke, Rolf
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (01)
  • [10] EMA: Direct Healthcare Professional Communication, 2020, Esbriet (pirfenidone): Important safety update and new recommendations to prevent Drug-Induced Liver Injury (DILI)